Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond

Genetic complexity and DNA damage repair defects are common in different cancer types and can induce tumor-specific vulnerabilities. Poly(ADP-ribose) polymerase (PARP) inhibitors exploit defects in the DNA repair pathway through synthetic lethality and have emerged as promising anticancer therapies,...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Drugs R D
Auteurs principaux: Boussios, Stergios, Abson, Charlotte, Moschetta, Michele, Rassy, Elie, Karathanasi, Afroditi, Bhat, Tahir, Ghumman, Faisal, Sheriff, Matin, Pavlidis, Nicholas
Format: Artigo
Langue:Inglês
Publié: Springer International Publishing 2020
Sujets:
Review Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7221042/
https://ncbi.nlm.nih.gov/pubmed/32215876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-020-00301-8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires